Market news

GAITHERSBURG, Md., September 09, 2026--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

GAITHERSBURG, Md., September 01, 2026--Katherine Stueland, CEO of GeneDx, has been named a 2026 Fierce 50 honoree for Health Equity

GAITHERSBURG, Md., August 24, 2026--GeneDx and Seattle Children’s show hospital-wide rapid genome sequencing accelerates accurate diagnosis and expands access to answers for children.

GeneDx Holdings Corp. (WGS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GAITHERSBURG, Md., August 11, 2026--GeneDx launches a new online offering to expand access to exome testing and help more children and families get answers sooner.

Genomic testing volume surged 32% as profitability returned ahead of schedule.

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.

Moby summary of GeneDx Holdings Corp.'s Q2 2026 earnings call

GeneDx returns to profitability ahead of schedule, driven by 32% exome and genome volume growth and expanded commercial coverage.

GeneDx (NASDAQ:WGS) reported second-quarter revenue of $114.4 million, above its prior guidance, as exome and genome testing volume reached a quarterly record of more than 30,000 tests. The company also returned to adjusted profitability one quarter earlier than previously expected, while maintainin

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +105.26% and +4.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GeneDx (WGS) reported Q2 adjusted earnings late Monday of $0.01 per diluted share, down from $0.55 a

GAITHERSBURG, Md., August 03, 2026--GeneDx (Nasdaq: WGS) today reported its financial and operational results for the second quarter of 2026.

LOS ANGELES , Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS ) for violations of §§10(b) and 20(a) of the Securities Exc...

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 31, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have unti...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 22, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have unti...

NewMediaWire Press Release.

Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery in Q2 2026, with the S&P 500 Index gaining 15.2%, marking its best quarter since 2020. A ceasefire between the United States […]

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have unti...

Polen Capital, an investment management company, released its second-quarter 2026 investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter can be downloaded here. Polen 5Perspectives Small Growth Composite Portfolio returned 33.22% gross and 32.83% net of fees, respectively, in the second quarter of 2026, compared to the 25.71% return of the […]

GAITHERSBURG, Md., July 16, 2026--GeneDx (Nasdaq: WGS) announced it will release financial results for the second quarter of 2026 after the market closes on Monday, August 3, 2026.

NewMediaWire Press Release.